大成中证360互联网+指数A（002236）成立日期2016年2月3日，最新规模6.98亿。今年以来收益 34.45%，同类排名1422/4220；近一年收益90.82%，同类排名730/3814；成立以来收益217.1%。 大成中证360互联网+指数A（002236）基金经理为夏高。 9月23日，艾隆科技跌5.14%，截至发稿，报20.13元/股，成交3768.19万元，换手率2.35%，总市值15.54 亿元。 资料显示，苏州艾隆科技股份有限公司位于中国(江苏)自由贸易试验区苏州片区苏州工业园区新庆路71 号，成立日期2006年1月20日，上市日期2021年3月29日，公司主营业务涉及公司专注于医疗物资的智能 管理领域,通过打造医疗物资智能管理设备及软件信息平台,为各级医疗服务机构提供医疗物资智能化管 理整体解决方案。主营业务收入构成为：智慧门急诊药房产品43.34%，维保16.55%，住院、静配中心 产品16.03%，其他(补充)8.27%，智能仓储产品7.83%，药事(学)信息化产品3.84%，病区(麻醉/精)药品 管理产品3.48%，其他0.35%，中药智能化产品0.32%。 从艾隆科技十大流通股东 ...

Group 1 - The core business of Ailong Technology focuses on intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for medical institutions [2] - As of August 8, 2025, the number of shareholders in Ailong Technology increased by 3.45% to 4,711, while the average circulating shares per person decreased by 3.33% to 16,387 shares [2] - For the first half of 2025, Ailong Technology reported a revenue of 131 million yuan, a year-on-year decrease of 8.11%, and a net profit attributable to shareholders of -8.39 million yuan, an increase of 55.47% year-on-year [2] Group 2 - Ailong Technology has distributed a total of 111 million yuan in dividends since its A-share listing, with 49.05 million yuan distributed over the past three years [3] - As of June 30, 2025, the sixth largest circulating shareholder of Ailong Technology is Dazheng Zhongzheng 360 Internet+ Index A, holding 828,300 shares as a new shareholder [3] Group 3 - On August 26, Ailong Technology's stock price increased by 0.40%, with a trading volume of 41.91 million yuan [1] - The financing buy-in amount for Ailong Technology on August 26 was 4.86 million yuan, with a net financing buy-in of 643,800 yuan, while the total financing and securities balance reached 68.61 million yuan, accounting for 3.92% of the circulating market value [1] - The securities lending data for Ailong Technology on August 26 showed no shares were lent or repaid, indicating a high level of securities lending balance at 0.00 shares, which is above the 90th percentile over the past year [1]

Group 1 - The core business of Suzhou Ailong Technology Co., Ltd. focuses on intelligent management of medical supplies, providing comprehensive solutions for medical institutions [1] - The company's main products include automated pharmacies, automated wards, and automated logistics [1] - As of the first quarter of 2025, the company reported revenue of 56.068 million yuan, a year-on-year increase of 0.44%, and a net profit of -14.166 million yuan, a year-on-year decrease of 1.42%, with a gross profit margin of 42.75% [1] Group 2 - Ailong Technology's latest closing price was 17.12 yuan, up 1.97%, with a market-to-book ratio of 1.79, marking a new low in 44 days, and a total market capitalization of 1.322 billion yuan [1] - As of the first quarter of 2025, there are four institutional holders of Ailong Technology, including three other entities and one fund, holding a total of 3.3392 million shares valued at 5.1 million yuan [1] - The company's PE (TTM) is -60.35, while the industry average PE is 62.88, indicating a significant divergence from industry performance [2]

Group 1 - The core business of Suzhou Ailong Technology Co., Ltd. focuses on intelligent management of medical supplies, providing comprehensive solutions for various medical service institutions [1][2] - The company has received multiple honors, including "National Torch Program Key High-tech Enterprise" and "Top Ten Medical Equipment Suppliers in China Hospital Construction" [1] - As of the first quarter of 2025, the company reported a revenue of 56.068 million yuan, with a year-on-year growth of 0.44%, and a net profit of -14.166 million yuan, reflecting a year-on-year decline of 1.42% [2] Group 2 - The latest market performance shows Ailong Technology's stock closed at 16.47 yuan, up 1.67%, with a market capitalization of 1.271 billion yuan [1] - The company has a price-to-earnings (PE) ratio of -58.05 and a price-to-book (PB) ratio of 1.72, compared to the industry average PE of 61.40 and PB of 4.26 [2] - As of the first quarter of 2025, four institutions held shares in Ailong Technology, with a total holding of 3.3392 million shares valued at 0.051 billion yuan [1][2]